Hib polysaccharide conjugate vaccine - Chongqing Zhifei Biological Products

Drug Profile

Hib polysaccharide conjugate vaccine - Chongqing Zhifei Biological Products

Alternative Names: Bixing Liugan Shixue Ganjun Jiehe Yimiao - Zhifei; Haemophilus Influenzae Type b Conjugate Vaccine - Zhifei

Latest Information Update: 09 Apr 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Chongqing Zhifei Biological Products
  • Class Haemophilus vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Haemophilus infections

Most Recent Events

  • 29 Oct 2012 Preregistration for Haemophilus infections in China (Parenteral)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top